Cymabay Therapeutics Inc [CBAY] stock for 191,849 USD was sold by Dorling Janet

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Cymabay Therapeutics Inc shares valued at $191,849 were sold by Dorling Janet on Feb 12 ’24. At $31.97 per share, Dorling Janet sold 6,000 shares. The insider’s holdings dropped to 0 shares worth approximately […]

Potential Price Increase for Cymabay Therapeutics Inc (CBAY) After Recent Insider Activity

Cymabay Therapeutics Inc’s recent filing unveils that its Director Dorling Janet unloaded Company’s shares for reported $0.19 million on Feb 12 ’24. In the deal valued at $31.97 per share,6,000 shares were sold. As a result of this transaction, Dorling Janet now holds 0 shares worth roughly $0.0. Then, McWherter Charles sold 18,403 shares, generating […]

Raymond James analysts downgrades a Mkt perform rating for Cymabay Therapeutics Inc (CBAY)

Cymabay Therapeutics Inc’s filing revealed that its Director Dorling Janet unloaded Company’s shares for reported $0.19 million on Feb 12 ’24. In the deal valued at $31.97 per share,6,000 shares were sold. As a result of this transaction, Dorling Janet now holds 0 shares worth roughly $0.0. Then, McWherter Charles sold 18,403 shares, generating $435,645 […]

Cymabay Therapeutics Inc [CBAY] stock for 191,849 USD was sold by Dorling Janet

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cymabay Therapeutics Inc shares valued at $191,849 were sold by Dorling Janet on Feb 12 ’24. At $31.97 per share, Dorling Janet sold 6,000 shares. The insider’s holdings dropped to 0 […]

Cymabay Therapeutics Inc [CBAY] Records 200-Day SMA of $16.67

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cymabay Therapeutics Inc shares valued at $191,849 were sold by Dorling Janet on Feb 12. At $31.97 per share, Dorling Janet sold 6,000 shares. The insider’s holdings dropped to 0 shares […]

Analysts review Cymabay Therapeutics Inc’s rating

Cymabay Therapeutics Inc’s recent filing unveils that its Director Dorling Janet unloaded Company’s shares for reported $0.19 million on Feb 12. In the deal valued at $31.97 per share,6,000 shares were sold. As a result of this transaction, Dorling Janet now holds 0 shares worth roughly $0.0. Then, McWherter Charles sold 18,403 shares, generating $435,645 […]

CBAY’s short interest falls to 9.3 million shares

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cymabay Therapeutics Inc shares valued at $191,849 were sold by Dorling Janet on Feb 12. At $31.97 per share, Dorling Janet sold 6,000 shares. The insider’s holdings dropped to 0 shares […]

CBAY’s latest rating updates from top analysts.

In a filing, Cymabay Therapeutics Inc revealed its Director Dorling Janet unloaded Company’s shares for reported $0.19 million on Feb 12. In the deal valued at $31.97 per share,6,000 shares were sold. As a result of this transaction, Dorling Janet now holds 0 shares worth roughly $0.0. Then, McWherter Charles sold 18,403 shares, generating $435,645 […]